Document ID: chunk:federal_register_of_legislation:F2022L00006:reg:9:p3
Version: federal_register_of_legislation:F2022L00006
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 8959–10213

1 - Dictionary.
(23)      having chronic renal failure at the time of the clinical worsening of goitre;
Note: chronic renal failure is defined in the Schedule 1 - Dictionary.
(24)      having a thyroid-stimulating, hormone-secreting pituitary adenoma at the time of the clinical worsening of goitre;
(25)      for nodular goitre only:
(a)           having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the thyroid gland at least 1 year before the clinical worsening of nodular goitre; or
(b)           undergoing a course of therapeutic radiation for cancer, where the thyroid gland was in the field of radiation, at least 1 year before the clinical worsening of nodular goitre;
            Note 1: Exposure to ionising radiation does not include radioiodine therapy for goitre or thyroid nodules.
            Note 2: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(26)      for thyrotoxic crisis only, having an acute precipitating event within the 48 hours before that clinical worsening of toxic goitre;
            Note: acute precipitating event and thyrotoxic crisis are defined in the Schedule 1 - Dictionary.
(27)      inability to obtain appropriate clinical management for goitre.